Anthropic and OpenEvidence Launched AI Clinical Tool
The free service provides medical decision support to physicians across nearly 100 low- and middle-income countries.
Updated on Sept. 23, 2026 in Artificial Intelligence
Live Poll
Should companies prioritize providing AI-powered clinical support to physicians in low-income nations?
Anthropic and OpenEvidence have launched an AI-powered clinical decision support tool in nearly 100 nations to assist medical providers. The platform, which utilizes peer-reviewed research and treatment guidelines, is intended to provide resources in regions such as Uganda, Angola, Sudan, Haiti, and Mongolia.
Why it matters
This initiative aims to bridge the global medical knowledge gap by ensuring clinicians in underserved areas have access to the same diagnostic support and treatment standards as their counterparts in the United States and Europe.
Anthropic provides the back-end AI infrastructure for the tool, while OpenEvidence adapts the system to local healthcare conditions and regional disease patterns.
The players
Anthropic
Anthropic is an AI safety and research company that develops large language models and infrastructure to support various industrial applications.
OpenEvidence
OpenEvidence is a technology platform that integrates clinical research and peer-reviewed data to support diagnostic decision-making for healthcare professionals.
Novo Nordisk
Novo Nordisk is a global healthcare company that previously partnered with Anthropic to utilize AI for accelerating pharmaceutical drug research.
The details
The platform answers physician queries by synthesizing data from peer-reviewed medical research and established treatment guidelines. By leveraging Anthropic's processing capabilities, the system provides real-time support tailored to the diagnostic resources available in each specific region.
Timeline
August 2026: U.S. clinicians logged 42 million OpenEvidence consultations.
September 22, 2026: Anthropic and OpenEvidence announced the international collaboration.
The Tech Race
This collaboration reflects a broader shift toward deploying large-scale AI infrastructure in the healthcare sector to replace legacy diagnostic support methods. It positions these firms against other tech rivals currently scaling medical AI solutions across international markets.
The tool provides physicians in low- and middle-income nations with immediate access to advanced medical research that previously required significant diagnostic infrastructure. This shift can improve local patient care by providing evidence-based treatment suggestions directly at the point of consultation.
The takeaway
The deployment of AI-driven diagnostic support signifies that high-level medical knowledge is becoming increasingly portable across global borders. Clinicians should monitor how these tools integrate with existing local health guidelines to maximize accuracy in diverse treatment environments.
Further reading
Explore more developments in Artificial Intelligence to see how models are reshaping professional industries.
Live Poll
Should companies prioritize providing AI-powered clinical support to physicians in low-income nations?
